Events Partner Content Welcome to the 2nd Chronic HBV Drug Development Summit Advance Combination Therapies, Outline Clinical Endpoints & Understand the Immunology Perspective to Achieve Functional Cures for Chronic Hepatitis B.
Events Partner Content 2nd Gene Therapy Immunogenicity Modulate, Measure & Predict Immune Response to GTx
Events Partner Content The 4th Annual Oncolytic Virotherapy Summit - Boston 2018 Join the 4th Oncolytic Virotherapy Summit in Boston
News Immunocore's T-cell therapy could provide HIV cure Treatment promises cure by reactivating immune cells to kill latent HIV-infected cells.
News Tanaka develops world’s first blood test for Zika virus Test is capable of detecting Zika virus infection directly from blood samples in just 10 to 15 minutes.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.